Abstract
Background: Curcumin and Thymoquinone are very well-known phytochemicals for their potent anti-inflammatory and anticancer properties. The major challenges for curcumin is its poor aqueous solubility and erratic oral bioavailability.
Objective: To develop a novel liquid self-nanoemulsifying drug delivery system (SNEDDS) containing curcumin and thymoquinone and further converted into a solid dosage form using adsorbents Syloid (R) and Neusilin (R) as the solid carrier.
Methods: The characterization of the liquid and solid SNEDDS was performed by particle size & zeta potential analysis, scanning electron microscopy, differential scanning calorimetry, fourier transform infrared spectroscopy and X-ray powder diffraction. The drug loading, and in vitro release studies were carried out to investigate the efficiency of curcumin release from SNEDDS.
Results: The liquid SNEDDS containing black seed oil showed excellent self-emulsification performance with transparent appearance. The results of characterization studies showed that solidification using 50% (w/w) Syloid (R) and Neusilin (R) in the liquid formulation yield free flowing powder with no agglomeration but Neusilin (R) produced smooth granules than Syloid (R) and kept the drugs stable in amorphous state. In vitro dissolution studies indicated that liquid SNEDDS formulations of F4 and its solid SNEDDS using Neusilin (R) provided high dissolution efficiency and reproducibility for curcumin and thymoquinone. However, Neusilin (R) showed higher rate of dissolution (more than 65%, p < 0.05) compared to Syloid (R) for curcumin.
Conclusions: Curcumin loaded-SNEDDS formulation containing thymoquinone in liquid & solid dosage forms were successfully developed with an increased drug loading and dissolution rate, which could be the potential combined delivery system for various anti-inflammatory and anti-cancer treatments. (C) 2019 The Authors. Production and hosting by Elsevier B.V.